# NIH Reporter #5P50CA165962-13

Targeted Therapies for Glioma

**Recipient:** Brigham and Women's Hospital

**Award Amount:** $2,441,596.00
**Ceiling:** $2,441,596.00

**Awarded:** August 27, 2026

**Identifier:** 5P50CA165962-13

NIH grant awarded to Brigham and Women's Hospital for research on targeted therapies for gliomas, focusing on pediatric and aggressive gliomas using innovative therapeutic approaches and clinical trials.

### Description

This project focuses on developing non-toxic, curative treatments for gliomas in children and young adults. The research involves three main projects targeting Pediatric Low-Grade Gliomas, Diffuse Midline Gliomas, and IDH Mutant Gliomas using various therapeutic strategies and clinical trials. The program is supported by cores for Pathology and Biostatistics, and an administrative core to facilitate collaborations among Harvard Medical School and associated hospitals.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11417207)